KRT19 and cholangiocarcinoma: The overexpression of these oncogenes successfully produces separate regions of HNF4α+;panCK+;CK19− poorly differentiated HCC and HNF4α−;CK19+ CCA, resembling the clinical cHCC-CCA tumor pathology [9,10,13].